Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1980 2
1981 3
1982 4
1983 1
1984 4
1985 3
1986 4
1987 1
1988 2
1989 2
1990 4
1992 6
1994 4
1996 4
1997 3
1998 2
1999 3
2000 3
2001 3
2002 2
2003 2
2004 3
2005 2
2006 4
2007 4
2008 7
2009 5
2010 3
2011 16
2012 14
2013 8
2014 6
2015 11
2016 15
2017 20
2018 23
2019 19
2020 22
2021 31
2022 44
2023 46
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: bui nq. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Clinical Trial.
Editorial.
Bui N. Bui N. Curr Probl Cancer. 2019 Aug;43(4):249. doi: 10.1016/j.currproblcancer.2019.07.002. Curr Probl Cancer. 2019. PMID: 31511143 No abstract available.
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).
Ingham M, Allred JB, Chen L, Das B, Kochupurakkal B, Gano K, George S, Attia S, Burgess MA, Seetharam M, Boikos SA, Bui N, Chen JL, Close JL, Cote GM, Thaker PH, Ivy SP, Bose S, D'Andrea A, Marino-Enriquez A, Shapiro GI, Schwartz GK. Ingham M, et al. Among authors: bui n. J Clin Oncol. 2023 Sep 1;41(25):4154-4163. doi: 10.1200/JCO.23.00402. Epub 2023 Jul 19. J Clin Oncol. 2023. PMID: 37467452
Molecular insights into desmoid tumors.
Bui N, Kummar S. Bui N, et al. Oncotarget. 2017 Sep 28;8(53):90608-90609. doi: 10.18632/oncotarget.21293. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207578 Free PMC article. No abstract available.
Current management and recent progress in desmoid tumors.
Zhou MY, Bui NQ, Charville GW, Ghanouni P, Ganjoo KN. Zhou MY, et al. Among authors: bui nq. Cancer Treat Res Commun. 2022;31:100562. doi: 10.1016/j.ctarc.2022.100562. Epub 2022 Apr 16. Cancer Treat Res Commun. 2022. PMID: 35460976 Free article. Review.
Computational tools supporting known miRNA identification.
Do VQ, Hoang-Thi C, Pham TT, Bui NL, Kim DT, Chu DT. Do VQ, et al. Among authors: bui nl. Prog Mol Biol Transl Sci. 2024;203:225-242. doi: 10.1016/bs.pmbts.2023.12.018. Epub 2024 Jan 30. Prog Mol Biol Transl Sci. 2024. PMID: 38360000 Review.
345 results